BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Heart
,
Nosology
,
Lipopolysaccharide
,
rs2230926
,
LEP
,
T cell differentiation
,
Leukemia
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
T- cell
NextBio Summary
General Info
Curated Studies
Most Correlated Studies
Cancer Gene Census - mutations in cancer genes
Th17 cell gene expression response to salt (NaCl)
CD4+ T cells from cord blood in a time course study of activation and TH17 polarization
GSK cancer cell line transcript profiling
Lymph node biopsies of ALK-positive or negative anaplastic large cell lymphoma patients
Explore Curated Studies Results
Literature
Most Relevant Literature
Lipid Metabolism in Tumor-Infiltrating T Cells.
Invariant natural killer T cells : Cellular immune regulators with cytotoxic potential].
Follicular T-cell regulation of alloantibody formation.
Target and Manufacturing of Chimeric Antigen Receptor T cells for T-cell Malignancies--Review].
Identification of Epitope-Specific T Cells in T-Cell Receptor Repertoires.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
CD4-specific CAR T Cells (CD4 CAR T Cells) for Relapsed/Refractory T Cell Malignancies
CAR-37 T Cells In Hematologic Malignancies
Anti-CD5 CAR T Cells for Relapsed/Refractory T Cell Malignancies
LCAR-T2C CAR-T Cells in Relapsed or Refractory CD4+ T-cell Lymphoma
CD19-Specific T Cells Post AlloSCT
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ